Postoperative chemotherapy for non–small cell lung cancer: A systematic review and meta-analysis

This publication has 17 references indexed in Scilit:

• Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2004
• Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 2003
• O-179 The Big Lung Trial (BLT): Determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the surgical setting
  Lung Cancer, 2003
• O-182 Randomized control study of adjuvant chemotherapy with UFT alone or plus cisplatin and vindesine in patients with completely resected non-small cell lung cancer
  Lung Cancer, 2003
• PL-2 A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I (T1N0M0, T2N0M0) adenocarcinoma of the lung
  Lung Cancer, 2003
• A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery
  Lung Cancer, 2003
• Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2002
• Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non-Small-Cell Lung Cancer
  Journal of Clinical Oncology, 2002
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
  BMJ, 1995
• A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1994